Literature DB >> 31032276

Validity and reliability of patient section of evidence-based medical records about doctor-patient building through integrated therapy of traditional Chinese and Western medicine (DPEBMR-P) in patients with gastrointestinal diseases.

Shuo Feng1, Lingxiao Chen2, Guihua Tian3, Jing Hu1, Yang Ding1, Zhengguang Du1, Hongkai Zhang1, Bo Li1, Yang Li4.   

Abstract

BACKGROUND: We developed an evidence-based medical record for doctor-patient relationship building through an integrated therapy of traditional Chinese and Western medicine (DPEBMR) to assess the efficacy in patients with digestive system diseases. The instrument was categorized into a doctor section and a patient section. In this article, our main goal was to test the validity and reliability of the patient's section for DPEBMR (DPEBMR-P).
METHODS: One hundred patients were recruited. Doctors and patients used a predefined format to jointly record the illness. Cronbach's α and factor analysis were used to evaluate the reliability and structure validity, respectively.
RESULTS: Cronbach's α of all 12 items from DPEBMR-P was 0.906, which demonstrated high reliability. The Kaiser-Meyer-Olkin value was 0.811 and Bartlett's spherical test value was 452.2 (P<0.05), which meant it was suitable for performing factor analysis. A total of 3 items were identified as factors, and each had high loading: items of mental status (0.584 to 0.833), items of therapeutic effect (0.518 to 0.797), and items of appetite (0.857 to 0.882).
CONCLUSIONS: The DPEBMR-P indicated substantial reliability and structure validity.

Entities:  

Keywords:  Gastrointestinal diseases; reliability; validity

Year:  2019        PMID: 31032276      PMCID: PMC6465450          DOI: 10.21037/atm.2018.12.27

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  13 in total

1.  Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey.

Authors:  Oriol Cunillera; Ricard Tresserras; Luis Rajmil; Gemma Vilagut; Pilar Brugulat; Mike Herdman; Anna Mompart; Antonia Medina; Yolanda Pardo; Jordi Alonso; John Brazier; Montse Ferrer
Journal:  Qual Life Res       Date:  2010-03-31       Impact factor: 4.147

2.  Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire.

Authors:  Y Chan; J Y L Ching; C M Y Cheung; K K F Tsoi; S Polder-Verkiel; S H Y Pang; W L Quan; K M Kee; F K L Chan; J J Y Sung; J C Y Wu
Journal:  Aliment Pharmacol Ther       Date:  2009-10-31       Impact factor: 8.171

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  [Clinical Trial of Acupuncture Treatment of Gastro-esophageal Reflex Disease by Needling Dorsal Segment of the Governor Vessel].

Authors:  Lu-jiao Gao; Xing-hua Bai
Journal:  Zhen Ci Yan Jiu       Date:  2016-04

5.  The development of the GERD-HRQL symptom severity instrument.

Authors:  V Velanovich
Journal:  Dis Esophagus       Date:  2007       Impact factor: 3.429

6.  Validation of a specific quality of life questionnaire for functional digestive disorders.

Authors:  O Chassany; P Marquis; B Scherrer; N W Read; T Finger; J F Bergmann; B Fraitag; J Geneve; C Caulin
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

7.  Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD).

Authors:  I K Wiklund; O Junghard; E Grace; N J Talley; M Kamm; S Veldhuyzen van Zanten; P Paré; N Chiba; D S Leddin; M A Bigard; R Colin; P Schoenfeld
Journal:  Eur J Surg Suppl       Date:  1998

8.  International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease.

Authors:  G Holtmann; O Chassany; K R Devault; H Schmitt; U Gebauer; H Doerfler; J R Malagelada
Journal:  Aliment Pharmacol Ther       Date:  2008-12-19       Impact factor: 8.171

9.  Development and validation of a disease-specific treatment satisfaction questionnaire for gastro-oesophageal reflux disease.

Authors:  K S Coyne; I Wiklund; J Schmier; K Halling; A Degl' Innocenti; D Revicki
Journal:  Aliment Pharmacol Ther       Date:  2003-11-01       Impact factor: 8.171

10.  The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease: the Reflux questionnaire.

Authors:  Susan Macran; Samantha Wileman; Garry Barton; Ian Russell
Journal:  Qual Life Res       Date:  2006-10-11       Impact factor: 3.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.